Retrospective Cohort Study
Copyright ©The Author(s) 2019.
World J Gastrointest Oncol. Nov 15, 2019; 11(11): 1011-1020
Published online Nov 15, 2019. doi: 10.4251/wjgo.v11.i11.1011
Table 1 Age distribution of the study cohorts
Early-onset CRCLater-onset CRCControl
N57106301011800420
Age, n (%)
25-29260 (5)-2336260 (20)
30-34480 (8)-2469830 (21)
35-39830 (15)-2409750 (20)
40-441400 (25)-2187280 (19)
45-492740 (48)-2348440 (20)
50-54-4370 (7)-
55-59-6210 (10)-
60-64-7400 (12)-
65-69-8550 (14)-
70-74-8920 (14)-
75-79-8400 (13)-
80-84-7290 (12)-
85-89-5830 (9)-
90+-4750 (8)-
Table 2 20-point data set observation of the study cohorts, n (%)
Early-onset CRCLater-onset CRCControl
N57106301011800420
Gender
Male2800 (49)32320 (51)4931130 (42)
Female2910 (51)30690 (49)6869290 (58)
Ethnicity
Caucasian3880 (68)52330 (83)6947160 (59)
African-American860 (15)8260 (13)1462790 (12)
Asian110 (2)1380 (2)258990 (2)
Symptoms
Abdominal pain3060 (54)24490 (39)2317490 (20)
Rectal pain170 (3)1260 (2)48200 (0.4)
Altered bowel function1440 (25)14610 (23)680420 (6)
Rectal bleeding790 (14)7960 (13)190310 (2)
Weight loss490 (9)7800 (12)147250 (1)
Family history
Of cancer1360 (24)9400 (15)308120 (3)
Of GI malignancy840 (15)4300 (7)70560 (1)
Of polyps60 (1)470 (1)15350 (0.1)
Social history
Tobacco use3600 (63)42360 (67)4838172 (41)
Alcohol use2000 (35)24850 (39)2832100 (24)
Comorbidities
Colitis710 (12)7270 (12)395260 (3)
BMI ≥ 303510 (61)36770 (58)4202120 (35)
Hypertension1710 (30)41740 (66)1534060 (13)
Hyperlipidemia1090 (19)33960 (54)1062040 (9)
Polyp history630 (11)8970 (14)155640 (1)
Table 3 Effect level comparison for early-onset colorectal cancer
Later-onset CRC
Control
Cohen’s dEffect levelCohen’s dEffect level
Gender (%)
Male-0.02-0.07+
Female0.02+-0.07-
Ethnicity (%)
Caucasian-0.20-0.09+
African-American0.04+0.05+
Asian-0.03--0.03-
Symptoms (%)
Abdominal pain0.14+0.37+ +
Rectal pain0.10+0.48+ +
Altered bowel function0.03+0.41+ +
Rectal bleeding0.02+0.55+ + +
Weight loss-0.10-0.48+ +
Family History (%)
Of cancer0.14+0.59+ + +
Of GI malignancy0.21+ +0.80+ + + +
Of polyps0.08+0.50+ + +
Social History (%)
Tobacco use-0.04-0.22+ +
Alcohol use-0.04-0.13+
Comorbidities (%)
Colitis0.02+0.34+ +
BMI ≥ 300.03+0.25+ +
Hypertension-0.36-0.25+ +
Hyperlipidemia-0.39-0.21+ +
Polyp history (%)-0.07-0.53+ + +